Início › Câncer de Mama › New Jersey › Newark
Ensaios clínicos de Câncer de Mama em Newark, NJ
18 estudos para Câncer de Mama estão buscando participantes em locais em Newark e arredores (num raio de aproximadamente 30 milhas). Abra um estudo para ver quem pode participar e como contatar a equipe.
Texto oficial do estudo (Inglês)
Recrutando participantes para um estudo? Destaque-o no topo desta página — $99 por 30 dias →
Phase IIIb Study of Ribociclib + ET in Early Breast Cancer
RecrutandoFase 3
- Summit Health, Florham Park · a 12 mi de distância
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RecrutandoEstudo observacionalVoluntários saudáveis bem-vindos
- Morristown Medical Center, Morristown · a 17 mi de distância
A Phase 2 Neoadjuvant Study of Zanidatamab in Combination With Chemotherapy in Participants With HER2-positive Breast Cancer
RecrutandoFase 2
- Medical Oncology Hematology Associates, Newark
A Clinical Study to Find the Optimal Dose of an Investigational Treatment Called BNT323 When Used in Combination With Another Investigational Treatment, BNT327, and to Test if That Combination Treatment is Safe and Beneficial for Patients With Advanced Breast Cancer
RecrutandoFase 1/2
- Summit Medical Group, Florham Park · a 12 mi de distância
ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer
RecrutandoFase 3
- Rutgers Cancer Institute of NJ (Rutgers, The State University of New Jersey), Newark
- Rutgers Cancer Institute of NJ (Rutgers, The State University of New Jersey), Livingston · a 9 mi de distância
- Summit Medical Group PA, Florham Park · a 12 mi de distância
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
RecrutandoFase 3
- Summit Medical Group, Florham Park · a 12 mi de distância
A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer
RecrutandoFase 3
- Summit Medical Group, Florham Park · a 12 mi de distância
Evaluating Minimal Residual Disease (MRD) Through Longitudinal Circulating Tumor DNA (ctDNA) Profiling in Breast Malignancies
RecrutandoEstudo observacional
- Summit Medical Group, Florham Park · a 12 mi de distância
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
RecrutandoFase 3
- Newark Beth Israel Medical Center, Newark
- Cooperman Barnabas Medical Center, Livingston · a 9 mi de distância
- Morristown Medical Center, Morristown · a 17 mi de distância
A Long-term Treatment Extension Study of Niraparib in Participants Who Completed a Prior GlaxoSmithKline/TESARO-sponsored Niraparib Study
RecrutandoFase 2
- GSK Investigational Site, Morristown · a 17 mi de distância
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
RecrutandoFase 3
- Morristown Medical Center, Morristown · a 17 mi de distância
SDM POSSIBLE: A Breast Cancer Treatment Decision Aid for Women 70+ With Low-Risk Stage I Breast Cancers
Recrutando
- Rutgers State University of New Jersey Medical School, Newark
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
RecrutandoEstudo observacional
- Morristown Medical Center, Morristown · a 17 mi de distância
Confirmatory Clinical Evaluation of Novilase® Laser Therapy for Focal Destruction of Malignant Breast Tumors
Recrutando
- Summit Health, Florham Park · a 12 mi de distância
RADIANT: Pre-op Radiation With Abemaciclib and Letrozole
RecrutandoFase 1
- RWJBarnabas Health Clara Maas Medical Center, Belleville · a 4 mi de distância
- Cooperman Barnabas Medical Center, Livingston · a 9 mi de distância
Statins for Reduction of Cardiac Toxicity in Patients Receiving HER2 Targeted
RecrutandoFase 2
- RWJBarnabas Health - Newark Beth Israel Medical Center, Newark
DPYD Pharmacogenomics and Fluoropyrimidine (FP) Dose-Adjustment
RecrutandoFase 4
- Cancer Center Initiative, Newark
- University Hospital, Newark
- RWJBarnabas Health Newark Beth Israel Medical Center, Newark
- e mais 2
S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity
RecrutandoFase 3
- Morristown Medical Center, Morristown · a 17 mi de distância
Ensaios de Câncer de Mama em outras cidades
- New York City, NY136 estudos
- Houston, TX126 estudos
- Boston, MA112 estudos
- Nashville, TN81 estudos
- Los Angeles, CA73 estudos
- Edison, NJ68 estudos
- St. Louis, MO64 estudos
- Queens, NY64 estudos
- Durham, NC64 estudos
- Chicago, IL59 estudos
- Philadelphia, PA56 estudos
- Dallas, TX55 estudos
Outros estudos em Newark
- Lesões da Medula Espinhal13 estudos
- Câncer de Pulmão de Não Pequenas Células13 estudos
- Leucemia Mieloide Aguda12 estudos
- Insuficiência Cardíaca10 estudos
- Câncer Metastático10 estudos
- Doença Cardiovascular9 estudos
- Câncer de Pâncreas9 estudos
- Melanoma8 estudos
- Câncer (todos os tipos)7 estudos
- Câncer de Pulmão7 estudos
- Doença de Crohn7 estudos
- Estenose da Valva Aórtica6 estudos
Fonte: ClinicalTrials.gov, dados obtidos em 6 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.